II级弥漫性胶质瘤的MRI特征与IDH突变状态:对诊断和预后的影响
回顾性分析100例II级弥漫性胶质瘤的术前MRI,其中78例IDH突变型、22例IDH野生型;IDH野生型与年龄较大、多灶性、脑干受累、无囊变及较低ADC相关,ADCmin阈值≤0.9×10-3 mm2/s区分IDH野生型的敏感度和特异度分别为91%和76%,低ADCmin合并IDH野生型预后更差。
要点
- IDH野生型II级弥漫性胶质瘤更常见于年龄>45岁、多灶性、脑干受累、无囊变及较低ADC。
- ADCmin阈值≤0.9×10-3 mm2/s区分IDH野生型的敏感度91%、特异度76%。
- 低ADCmin合并IDH野生型状态比单纯IDH野生型预后更差。
核心结论
- IDH野生型II级弥漫性胶质瘤与较低ADC及不良临床结局相关,联合IDH突变状态与ADC可能更准确预测II级弥漫性胶质瘤患者的临床结局。
研究设计与样本
- 回顾性研究,纳入100例II级弥漫性胶质瘤,术前MRI评估定性肿瘤特征及定量扩散和灌注指标,采用Logistic回归和ROC分析MRI特征与IDH突变状态的关系,Kaplan-Meier和Cox比例风险模型评估IDH突变状态、1p19q共缺失、MRI特征、切除范围与临床结局的关联。
关键影像表现/征象
- IDH野生型肿瘤与年龄较大、多灶性、脑干受累、无囊变及较低表观扩散系数(ADC)相关。
- 多变量回归显示年龄>45岁及低ADCmin、平均ADC和最大ADC值独立与IDH突变状态相关。
诊断标准与关键数值
- ADCmin阈值≤0.9×10-3 mm2/s定义IDH野生型II级弥漫性胶质瘤的敏感度为91%、特异度为76%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Grade II diffuse gliomas (DGs) with isocitrate dehydrogenase (IDH) mutations are associated with better prognosis than their IDH wild-type counterparts. We sought to determine the MRI characteristics associated with IDH mutational status and ascertain whether MRI considered in combination with IDH mutational status can better predict the clinical outcomes of grade II DGs.
MATERIALS AND METHODS: Preoperative MRI examinations were retrospectively studied for qualitative tumor characteristics, including location, extent, cortical involvement, margin sharpness, cystic component, mineralization or hemorrhage, and contrast enhancement. Quantitative diffusion and perfusion metrics were also assessed. Logistic regression and ROC analyses were used to evaluate the relationship between MRI features and IDH mutational status. The association between IDH mutational status, 1p19q codeletion, MRI features, extent of resection, and clinical outcomes was assessed by Kaplan-Meier and Cox proportional hazards models.
RESULTS: Of 100 grade II DGs, 78 were IDH mutant and 22 were IDH wild type. IDH wild-type tumors were associated with older age, multifocality, brainstem involvement, lack of cystic change, and a lower apparent diffusion coefficient (ADC). Multivariable regression showed that age older than 45 years as well as low minimum ADC (ADCmin), mean ADC, and maximum ADC values were independently associated with IDH mutational status. Of these, an ADCmin threshold of 0.9 × 10-3 mm2/s or less provided the greatest sensitivity and specificity (91% and 76%, respectively) in defining IDH wild-type grade II DGs. Combining low ADCmin with IDH wild-type status conferred worse outcomes than did IDH wild-type status alone.
CONCLUSION: IDH wild-type grade II DGs are associated with a lower ADC and poor clinical outcomes. Combining IDH mutational status and ADC may allow more accurate prediction of clinical outcomes for patients with grade II DGs.
引用
- Villanueva-Meyer JE, Wood MD, Choi BS, et al. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis. AJR Am J Roentgenol. 2017. PMID: 29261348. doi:10.2214/AJR.17.18457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。